{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:54:11Z","timestamp":1788926051775,"version":"build-2803163510"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:00:00Z","timestamp":1624060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:00:00Z","timestamp":1624060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010054","name":"University of Roehampton","doi-asserted-by":"publisher","award":["Doctorate Scholarship"],"award-info":[{"award-number":["Doctorate Scholarship"]}],"id":[{"id":"10.13039\/100010054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Rationale<\/jats:title>\n                <jats:p>Abnormal functioning of the inhibitory gamma-aminobutyric acid (GABA) and excitatory (glutamate) systems is proposed to play a role in the development of schizophrenia spectrum disorder. Although results are mixed, previous 1H-magnetic resonance spectroscopy (MRS) studies in schizophrenia and clinical high-risk samples report these metabolites are altered in comparison to healthy controls. Currently, however, there are few studies of these metabolites in schizotypy samples, a personality dimension associated with the experience of schizophrenia and psychosis-like symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>We investigated if GABA and glutamate metabolite concentrations are altered in people with high schizotypy. We also explored the relationship between resilience to stress, GABA metabolite concentrations and schizotypy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used MRS to examine GABA and glutamate levels in the medial prefrontal cortex in people with low and high schizotypy traits as assessed with the Schizotypal Personality Questionnaire. Resilience to stress was assessed using the Connor-Davidson Resilience Scale.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to individuals with low schizotypy traits, high schizotypy individuals showed lower cortical prefrontal GABA (<jats:italic>F<\/jats:italic> (1,38)\u2009=\u20095.18, <jats:italic>p<\/jats:italic>\u2009=\u20090.03, <jats:italic>\u03b7<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.09) and glutamate metabolite levels (<jats:italic>F<\/jats:italic> (1, 49)\u2009=\u20096.25, <jats:italic>p<\/jats:italic>\u2009=\u20090.02, <jats:italic>\u03b7<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.02). Furthermore, participants with high GABA and high resilience levels were significantly more likely to be in the low schizotypy group than participants with low GABA and high resilience or high GABA and low resilience (95% CI 1.07\u20131.34, <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings demonstrate that subclinical schizotypal traits are associated with abnormal functioning of both inhibitory and excitatory systems and suggest that these transmitters are implicated in a personality trait believed to be on a continuum with psychosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00213-021-05867-y","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T08:03:00Z","timestamp":1624089780000},"page":"2459-2470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Reduced cortical GABA and glutamate in high schizotypy"],"prefix":"10.1007","volume":"238","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9947-2846","authenticated-orcid":false,"given":"Petya","family":"Kozhuharova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea O.","family":"Diaconescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,19]]},"reference":[{"issue":"14","key":"5867_CR1","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1523\/JNEUROSCI.18-14-05545.1998","volume":"18","author":"B Adams","year":"1998","unstructured":"Adams B, Moghaddam B (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18(14):5545\u20135554","journal-title":"J Neurosci"},{"issue":"4","key":"5867_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1001\/archpsyc.1995.03950160008002","volume":"52","author":"S Akbarian","year":"1995","unstructured":"Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE, Jones EG (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52(4):258\u2013266","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"5867_CR3","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1037\/a0034793","volume":"122","author":"N Barrantes-Vidal","year":"2013","unstructured":"Barrantes-Vidal N, Chun CA, Myin-Germeys I, Kwapil TR (2013) Psychometric schizotypy predicts psychotic-like, paranoid, and negative symptoms in daily life. J Abnorm Psychol 122(4):1077","journal-title":"J Abnorm Psychol"},{"issue":"2","key":"5867_CR4","first-page":"S408","volume":"41","author":"N Barrantes-Vidal","year":"2014","unstructured":"Barrantes-Vidal N, Grant P, Kwapil T (2014) The role of schizotypy in the study of the etiology of schizophrenia spectrum disorders. Schizophr Bull 41(2):S408\u2013S441","journal-title":"Schizophr Bull"},{"issue":"4","key":"5867_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0278-5846(03)00080-0","volume":"27","author":"A Becker","year":"2003","unstructured":"Becker A, Peters B, Schroeder H, Mann T, Guether G, Grecksch G (2003) Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27(4):687\u2013700","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1\u20133","key":"5867_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.schres.2008.11.020","volume":"108","author":"JS Bedwell","year":"2009","unstructured":"Bedwell JS, Kamath V, Compton MT (2009) The relationship between interview-based schizotypal personality dimension scores and thecontinuous performance test. Schizophr Res 108(1\u20133):158\u2013162","journal-title":"Schizophr Res"},{"key":"5867_CR7","doi-asserted-by":"crossref","unstructured":"Bustillo JR, Chen H, Gasparovic C, Mullins P, Caprihan A, Qualls C ... & Posse S (2011) Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla. Biol Psychiatry 69(1):19-27","DOI":"10.1016\/j.biopsych.2010.08.024"},{"issue":"6","key":"5867_CR8","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/jts.20271","volume":"20","author":"L Campbell-Sills","year":"2007","unstructured":"Campbell-Sills L, Stein M (2007) Psychometric analysis and refinement of the Connor-Davidson resilience scale (CD-RISC): validation of a 10-item measure of resilience. J Trauma Stress 20(6):1019\u20131028","journal-title":"J Trauma Stress"},{"key":"5867_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.nicl.2014.03.007","volume":"4","author":"C Chen","year":"2014","unstructured":"Chen C, Stanford A, Mao X, Abi-Dargham A, Shungu D, Lisanby S, Kegeoes L (2014) GABA level, gamma oscillation, and working memory performance in schizophrenia. NeuroImage Clinical 4:531\u2013539","journal-title":"NeuroImage Clinical"},{"issue":"6","key":"5867_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00004424-199606000-00006","volume":"31","author":"B Choe","year":"1996","unstructured":"Choe B, Suh T, Shinn K, Lee C, Lee C, Paik I (1996) Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy. Invest Radiol 31(6):345\u2013352","journal-title":"Invest Radiol"},{"issue":"2","key":"5867_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/0022034512454294","volume":"24","author":"NJ Cochrane","year":"2012","unstructured":"Cochrane NJ, Reynolds EC (2012) Calcium phosphopeptides\u2014mechanisms of action and evidence for clinical efficacy. Adv Dent Res 24(2):41\u201347","journal-title":"Adv Dent Res"},{"issue":"2","key":"5867_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1503\/jpn.170201","volume":"44","author":"T Da Silva","year":"2019","unstructured":"Da Silva T, Hafizi S, Rusjan P, Houle S, Wilson A, Prce I, Mizrahi R (2019) GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study. J Psychiatry Neurosci 44(2):111","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"5867_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/ijnp\/pyv105","volume":"19","author":"C de la Fuente-Sandoval","year":"2016","unstructured":"de la Fuente-Sandoval C, Reyes-Madrigal F, Mao X, Leon-Ortiz P, Rodriguez-Mayoral O, Solis-Vivanco R, Shungu D (2016) Cortico-striatal GABAergic and glutamatergic dysregulations in subjects at ultra-high risk for psychosis investigated with proton magnetic resonance spectroscopy. Int J Neuropsychopharmacol 19(3):105","journal-title":"Int J Neuropsychopharmacol"},{"key":"5867_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.pnpbp.2013.05.006","volume":"45","author":"J Deslauriers","year":"2013","unstructured":"Deslauriers J, Larouche A, Sarret P, Grignon S (2013) Combination of prenatal immune challenge and restraint stress affects prepulse inhibition and dopaminergic\/GABAergic markers. Prog Neuropsychopharmacol\u00a0Biol Psychiatry 45:156\u2013164","journal-title":"Prog Neuropsychopharmacol\u00a0Biol Psychiatry"},{"issue":"10","key":"5867_CR15","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/npp.2013.101","volume":"38","author":"Y Du","year":"2013","unstructured":"Du Y, Grace A (2013) Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia. Neuropsychopharmacology 38(10):1881\u20131888","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"5867_CR16","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1038\/npp.2014.143","volume":"39","author":"A Egerton","year":"2014","unstructured":"Egerton A, Stone JM, Chaddock CA, Barker GJ, Bonoldi I, Howard RM, Merritt K, Allen P, Howes OD, Murray RM, McLean MA, Lythgoe  DJ, O'Gorman RL, McGuire PK (2014) Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis. Neuropsychopharmacology 39(12):2891\u20132899","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"5867_CR17","doi-asserted-by":"publisher","first-page":"e1147","DOI":"10.1038\/tp.2017.124","volume":"7","author":"A Egerton","year":"2017","unstructured":"Egerton A, Modinos G, Ferrera D, McGuire P (2017) Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis. Transl Psychiatry 7(6):e1147\u2013e1147","journal-title":"Transl Psychiatry"},{"issue":"5","key":"5867_CR18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.biopsych.2010.09.038","volume":"69","author":"T Enomoto","year":"2011","unstructured":"Enomoto T, Maric TT, Floresco SB (2011) Reducing prefrontal gamma-aminobutyric acid activity induces cognitive, behavioral, and dopaminergic abnormalities that resemble schizophrenia. Biol Psychiat 69(5):432\u2013441","journal-title":"Biol Psychiat"},{"key":"5867_CR19","first-page":"18","volume":"5","author":"U Ettinger","year":"2014","unstructured":"Ettinger U, Meyhofer I, Steffens M, Wagner M, Koutsouleris N (2014) Genetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia. Front Psych 5:18","journal-title":"Front Psych"},{"issue":"7","key":"5867_CR20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3109\/15622975.2011.559269","volume":"13","author":"U Ettinger","year":"2012","unstructured":"Ettinger U, Williams SC, Meisenzahl EM, M\u00f6ller HJ, Kumari V, Koutsouleris N (2012) Association between brain structure and psychometric schizotypy in healthy individuals. World J Biol Psychiatry 13(7):544\u2013549","journal-title":"World J Biol Psychiatry"},{"issue":"suppl_2","key":"5867_CR21","doi-asserted-by":"publisher","first-page":"S417","DOI":"10.1093\/schbul\/sbu190","volume":"41","author":"U Ettinger","year":"2015","unstructured":"Ettinger U, Mohr C, Gooding DC, Cohen AS, Rapp A, Haenschel C, Park S (2015) Cognition and brain function in schizotypy: a selective review. Schizophr Bull 41(suppl_2):S417\u2013S426","journal-title":"Schizophr Bull"},{"issue":"2","key":"5867_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/0013164493053002011","volume":"53","author":"D Fischer","year":"1993","unstructured":"Fischer D, Fick C (1993) Measuring social desirability: short forms of the Marlowe-Crowne social desirability scale. Educ Psychol Measur 53(2):417\u2013424","journal-title":"Educ Psychol Measur"},{"issue":"1","key":"5867_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jad.2004.12.011","volume":"86","author":"LM Furlanetto","year":"2005","unstructured":"Furlanetto LM, Mendlowicz MV, Bueno JR (2005) The validity of the Beck Depression Inventory-Short Form as a screening and diagnostic instrument for moderate and severe depression in medical inpatients. J Affect Disord 86(1):87\u201391","journal-title":"J Affect Disord"},{"issue":"1","key":"5867_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/schbul\/sbs136","volume":"40","author":"P Fusar-Poli","year":"2014","unstructured":"Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK (2014) Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull 40(1):120\u2013131","journal-title":"Schizophr Bull"},{"key":"5867_CR25","doi-asserted-by":"crossref","unstructured":"Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, Mullins PG, Posse S, Jung RE, Morrison LA (2006) Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 55(6):1219\u20131226","DOI":"10.1002\/mrm.20901"},{"issue":"4","key":"5867_CR26","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/npp.2011.298","volume":"37","author":"F Gastambide","year":"2012","unstructured":"Gastambide F, Cotel M, Gilmour G, O\u2019Neill M, Robbins T, Tricklebank M (2012) Selective remediation of reversal learning deficits in the neurodevelopmental MAM model of schizophrenia by a novel mGlu5 positive allosteric modulator. Neuropsychopharamacology 37(4):1057\u20131066","journal-title":"Neuropsychopharamacology"},{"issue":"3","key":"5867_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00213-014-3687-y","volume":"232","author":"B Godlewska","year":"2015","unstructured":"Godlewska B, Near J, Cowen P (2015) Neurochemistry of major depression: a study using magnetic resonance spectroscopy. Psychopharmacology 232(3):501\u2013507","journal-title":"Psychopharmacology"},{"issue":"1\u20133","key":"5867_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.schres.2009.04.026","volume":"112","author":"N Goto","year":"2009","unstructured":"Goto N, Yoshimura R, Moriya J, Kakeda S, Ueda N, Ikenouchi-Sugita A, Nakamura J (2009) Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study. Schizophr Res 112(1\u20133):192\u2013193","journal-title":"Schizophr Res"},{"issue":"11","key":"5867_CR29","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.biopsych.2006.05.046","volume":"60","author":"Y Goto","year":"2006","unstructured":"Goto Y, Grace A (2006) Alterations in medial prefrontal cortical activity and plasticity in rats with disruption of cortical development. Biol Psychiat 60(11):1259\u20131267","journal-title":"Biol Psychiat"},{"key":"5867_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1177\/0963721410378032","volume":"19","author":"A Grace","year":"2010","unstructured":"Grace A (2010) Ventral hippocampus, interneurons, and schizophrenia: a new understanding of the pathophysiology of schizophrenia and its implications for treatment and prevention. Curr Dir Psychol Sci 19:232\u2013237","journal-title":"Curr Dir Psychol Sci"},{"key":"5867_CR31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn.2016.57","volume":"17","author":"A Grace","year":"2016","unstructured":"Grace A (2016) Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci 17:524\u2013532","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"5867_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1037\/1040-3590.19.4.369","volume":"19","author":"DF Gr\u00f6s","year":"2007","unstructured":"Gr\u00f6s DF, Antony MM, Simms LJ, McCabe RE (2007) Psychometric properties of the state-trait inventory for cognitive and somatic anxiety (STICSA): comparison to the state-trait anxiety inventory (STAI). Psychol Assess 19(4):369","journal-title":"Psychol Assess"},{"issue":"50","key":"5867_CR33","doi-asserted-by":"publisher","first-page":"17102","DOI":"10.1523\/JNEUROSCI.4623-10.2010","volume":"30","author":"AJ Gruber","year":"2010","unstructured":"Gruber AJ, Calhoon GG, Shusterman I, Schoenbaum G, Roesch MR, O\u2019Donnell P (2010) More is less: a disinhibited prefrontal cortex impairs cognitive flexibility. J Neurosci 30(50):17102\u201317110","journal-title":"J Neurosci"},{"issue":"7\u20138","key":"5867_CR34","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.neuropharm.2010.10.021","volume":"60","author":"A Guidotti","year":"2011","unstructured":"Guidotti A, Auta J, Chen Y, Davis J, Dong E, Gavin D, Sharma R (2011) Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 60(7\u20138):1007\u20131016","journal-title":"Neuropharmacology"},{"issue":"1","key":"5867_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/sj.mp.4001558","volume":"10","author":"P Harrison","year":"2005","unstructured":"Harrison P, Weinberger D (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10(1):40\u201368","journal-title":"Mol Psychiatry"},{"issue":"2\u20133","key":"5867_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0920-9964(99)00151-6","volume":"51","author":"JD Huppert","year":"2001","unstructured":"Huppert JD, Weiss KA, Lim R, Pratt S, Smith TE (2001) Quality of life in schizophrenia: contributions of anxiety and depression. Schizophr Res 51(2\u20133):171\u2013180","journal-title":"Schizophr Res"},{"issue":"3","key":"5867_CR37","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.neuroimage.2006.10.023","volume":"34","author":"R Huster","year":"2007","unstructured":"Huster R, Westerhausen R, Kreuder F, Schweiger E, Wittling W (2007) Morphologic asymmetry of the human anterior cingulate cortex. Neuroimage 34(3):888\u2013895","journal-title":"Neuroimage"},{"issue":"6","key":"5867_CR38","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.biopsych.2005.01.003","volume":"57","author":"R Keefe","year":"2005","unstructured":"Keefe R, Eesley C, Poe M (2005) Defining a cognitive function decrement in schizophrenia. Biol Psychiat 57(6):688\u2013691","journal-title":"Biol Psychiat"},{"key":"5867_CR39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neubiorev.2019.10.010","volume":"108","author":"P Kozhuharova","year":"2019","unstructured":"Kozhuharova P, Saviola F, Ettinger U, Allen P (2019) Neural correlates of social cognition in populations at risk of psychosis: a systematic review. Neurosci Biobehav Rev 108:94\u2013111","journal-title":"Neurosci Biobehav Rev"},{"key":"5867_CR40","doi-asserted-by":"crossref","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, ... & Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51(3):199-214","DOI":"10.1001\/archpsyc.1994.03950030035004"},{"issue":"suppl_2","key":"5867_CR41","doi-asserted-by":"publisher","first-page":"S366","DOI":"10.1093\/schbul\/sbu186","volume":"41","author":"TR Kwapil","year":"2015","unstructured":"Kwapil TR, Barrantes-Vidal N (2015) Schizotypy: looking back and moving forward. Schizophr Bull 41(suppl_2):S366\u2013S373","journal-title":"Schizophr Bull"},{"key":"5867_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.eurpsy.2019.08.006","volume":"62","author":"TL Le","year":"2019","unstructured":"Le TL, Cohen AS, Allred S, Pham C, Lewis S, Barkus E (2019) Stress and cognitive biases in schizotypy: a two-site study of bias against disconfirmatory evidence and jumping to conclusions. Eur Psychiatry 62:20\u201327","journal-title":"Eur Psychiatry"},{"issue":"2\u20133","key":"5867_CR43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.schres.2005.11.024","volume":"83","author":"KE Lewandowski","year":"2006","unstructured":"Lewandowski KE, Barrantes-Vidal N, Nelson-Gray RO, Clancy C, Kepley HO, Kwapil TR (2006) Anxiety and depression symptoms in psychometrically identified schizotypy. Schizophr Res 83(2\u20133):225\u2013235","journal-title":"Schizophr Res"},{"issue":"1","key":"5867_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","volume":"35","author":"D Lewis","year":"2012","unstructured":"Lewis D, Curley A, Glausier J, Volk D (2012) Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci 35(1):57\u201367","journal-title":"Trends Neurosci"},{"key":"5867_CR45","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nrn1648","volume":"6","author":"D Lewis","year":"2005","unstructured":"Lewis D, Hashimoto T, Volk D (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312\u2013324","journal-title":"Nat Rev Neurosci"},{"key":"5867_CR46","doi-asserted-by":"crossref","unstructured":"Lieberman JA, Girgis RR, Brucato G, Moore H, Provenzano F, Kegeles L, ... & Schobel SA (2018) Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention. Mol Psychiatry 23(8):1764-1772","DOI":"10.1038\/mp.2017.249"},{"issue":"6","key":"5867_CR47","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1017\/S0033291712001626","volume":"43","author":"R Linscott","year":"2013","unstructured":"Linscott R, Van Os J (2013) An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders. Psychol Med 43(6):1133\u20131149","journal-title":"Psychol Med"},{"issue":"5","key":"5867_CR48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","volume":"31","author":"J Lisman","year":"2008","unstructured":"Lisman J, Coyle J, Green R, Javitt D, Benes F, Heckers S, Grace A (2008) Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 31(5):234\u2013242","journal-title":"Trends Neurosci"},{"issue":"9","key":"5867_CR49","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.tips.2011.05.001","volume":"32","author":"DJ Lodge","year":"2011","unstructured":"Lodge DJ, Grace AA (2011) Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia. Trends Pharmacol Sci 32(9):507\u2013513","journal-title":"Trends Pharmacol Sci"},{"issue":"2\u20133","key":"5867_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF03033801","volume":"14","author":"D Lodge","year":"2008","unstructured":"Lodge D, Grace A (2008) Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia. Neurotox Res 14(2\u20133):97\u2013104","journal-title":"Neurotox Res"},{"issue":"8","key":"5867_CR51","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1523\/JNEUROSCI.5419-08.2009","volume":"29","author":"D Lodge","year":"2009","unstructured":"Lodge D, Behrens M, Grace A (2009) A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci 29(8):2344\u20132354","journal-title":"J Neurosci"},{"issue":"13","key":"5867_CR52","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.1523\/JNEUROSCI.5248-12.2013","volume":"33","author":"P Mailly","year":"2013","unstructured":"Mailly P, Aliane V, Groenewegen H, Haber S, Deniau J (2013) The rat prefrontostriatal system analyzed in 3D: evidence for multiple interacting functional units. J Neurosci 33(13):5718\u20135727","journal-title":"J Neurosci"},{"issue":"1p2","key":"5867_CR53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1399-5618.2007.00564.x","volume":"10","author":"GS Malhi","year":"2008","unstructured":"Malhi GS, Green M, Fagiolini A, Peselow ED, Kumari V (2008) Schizoaffective disorder: diagnostic issues and future recommendations. Bipolar Disord 10(1p2):215\u2013230","journal-title":"Bipolar Disord"},{"issue":"1","key":"5867_CR54","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/schbul\/sbr069","volume":"39","author":"A Marsman","year":"2013","unstructured":"Marsman A, van den Heuvel M, Klomp D, Kahn R, Luijten P, Hulshoff Pol H (2013) Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies. Schizophr Bull 39(1):120\u2013129","journal-title":"Schizophr Bull"},{"issue":"1","key":"5867_CR55","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1134\/S1607672916030029","volume":"468","author":"P Menschikov","year":"2016","unstructured":"Menschikov P, Semenova N, Ublinskiy M, Akhadov T, Keshishyan R, Lebedeva I, Varfolomeev S (2016) 1 H-MRS and MEGA-PRESS pulse sequence in the study of balance of inhibitory and excitatory neurotransmitters in the human brain of ultra-high risk of schizophrenia patients. Dokl Biochem Biophys 468(1):168\u2013172","journal-title":"Dokl Biochem Biophys"},{"issue":"7","key":"5867_CR56","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jamapsychiatry.2016.0442","volume":"73","author":"K Merritt","year":"2016","unstructured":"Merritt K, Egerton A, Kempton MJ, Taylor MJ, McGuire PK (2016) Nature of glutamate alterations in schizophrenia: a meta-analysis of proton magnetic resonance spectroscopy studies. JAMA Psychiat 73(7):665\u2013674","journal-title":"JAMA Psychiat"},{"key":"5867_CR57","first-page":"151","volume":"4","author":"K Merritt","year":"2013","unstructured":"Merritt K, McGuire P, Egerton A (2013) Relationship between glutamate dysfunction and symptoms and cognitive function in psychosis. Front Psych 4:151","journal-title":"Front Psych"},{"issue":"5","key":"5867_CR58","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/mrm.21043","volume":"56","author":"K Mlyn\u00e1rik","year":"2006","unstructured":"Mlyn\u00e1rik K, Gambarota G, Frenkel H, Gruetter R (2006) Localized short-echo-time proton MR spectroscopy with full signal-intensity acquisition. Magn Reson Med 56(5):965\u2013970","journal-title":"Magn Reson Med"},{"issue":"4","key":"5867_CR59","doi-asserted-by":"publisher","first-page":"e1083","DOI":"10.1038\/tp.2017.53","volume":"7","author":"G Modinos","year":"2017","unstructured":"Modinos G, McLaughlin A, Egerton A, McMullen K, Kumari V, Barker G, Williams S (2017) Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study. Transl Psychiatry 7(4):e1083\u2013e1083","journal-title":"Transl Psychiatry"},{"issue":"9","key":"5867_CR60","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1017\/S0033291709991875","volume":"40","author":"G Modinos","year":"2010","unstructured":"Modinos G, Mechelli A, Ormel J, Groenewold NA, Aleman A, McGuire PK (2010) Schizotypy and brain structure: a voxel-based morphometry study. Psychol Med 40(9):1423\u20131431","journal-title":"Psychol Med"},{"issue":"2","key":"5867_CR61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/ijnp\/pyx076","volume":"21","author":"G Modinos","year":"2018","unstructured":"Modinos G, Simsek F, Horder J, Bossong M, Bonoldi I, Azis M, Howes O (2018) Cortical GABA in subjects at ultra-high risk of psychosis: relationship to negative prodromal symptoms. Int J Neuropsychopharmacol 21(2):114\u2013119","journal-title":"Int J Neuropsychopharmacol"},{"issue":"8","key":"5867_CR62","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17(8):2921\u20132927","journal-title":"J Neurosci"},{"issue":"3","key":"5867_CR63","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.biopsych.2006.01.003","volume":"60","author":"H Moore","year":"2006","unstructured":"Moore H, Jentsch J, Ghajarnia M, Geyer M (2006) A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol Psychiat 60(3):253\u2013264","journal-title":"Biol Psychiat"},{"issue":"5","key":"5867_CR64","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/schbul\/sbt124","volume":"40","author":"T Natsubori","year":"2014","unstructured":"Natsubori T, Inoue H, Abe O, Takano Y, Iwashiro N, Aoki Y, Sasaki H (2014) Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia. Schizophr Bull 40(5):1128\u20131139","journal-title":"Schizophr Bull"},{"issue":"3","key":"5867_CR65","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.neubiorev.2013.01.004","volume":"37","author":"MT Nelson","year":"2013","unstructured":"Nelson MT, Seal ML, Pantelis C, Phillips LJ (2013) Evidence of a dimensional relationship between schizotypy and schizophrenia: a systematic review. Neurosci Biobehav Rev 37(3):317\u2013327","journal-title":"Neurosci Biobehav Rev"},{"key":"5867_CR66","doi-asserted-by":"crossref","unstructured":"Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, ... & Pfleiderer B (2007) Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. J Psychiatr Res 41(8):625-634","DOI":"10.1016\/j.jpsychires.2006.07.002"},{"issue":"7","key":"5867_CR67","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.biopsych.2010.05.016","volume":"68","author":"D \u00d6ng\u00fcr","year":"2010","unstructured":"\u00d6ng\u00fcr D, Prescot A, McCarthy J, Cohen B, Renshaw P (2010) Elevated gamma-aminobutyric acid levels in chronic schizophrenia. Biol Psychiat 68(7):667\u2013670","journal-title":"Biol Psychiat"},{"issue":"3","key":"5867_CR68","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuropharm.2011.01.049","volume":"62","author":"SB Powell","year":"2012","unstructured":"Powell SB, Sejnowski TJ, Behrens MM (2012) Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumininterneuron maturation in rodent models of schizophrenia. Neuropharmacology 62(3):1322\u20131331","journal-title":"Neuropharmacology"},{"issue":"4","key":"5867_CR69","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/schbul\/17.4.555","volume":"17","author":"A Raine","year":"1991","unstructured":"Raine A (1991) The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull 17(4):555\u2013565","journal-title":"Schizophr Bull"},{"issue":"3","key":"5867_CR70","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/sj.npp.1300642","volume":"30","author":"LM Rowland","year":"2005","unstructured":"Rowland LM, Astur RS, Jung RE, Bustillo JR, Lauriello J, Yeo RA (2005) Selective cognitive impairments associated with NMDA receptor blockade in humans. Neuropsychopharmacology 30(3):633\u2013639","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"5867_CR71","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/schbul\/sbs092","volume":"39","author":"L Rowland","year":"2013","unstructured":"Rowland L, Kontson K, West J, Edden R, Zhu H, Wijtenburg S, Barker P (2013) In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr Bull 39(5):1096\u20131104","journal-title":"Schizophr Bull"},{"issue":"1\u20133","key":"5867_CR72","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.schres.2007.05.024","volume":"99","author":"N R\u00fcsch","year":"2008","unstructured":"R\u00fcsch N, van Elsl L, Valerius G, B\u00fcchert M, Thiel T, Ebert D, Olbrich H (2008) Neurochemical and structural correlates of executive dysfunction in schizophrenia. Schizophr Res 99(1\u20133):155\u2013163","journal-title":"Schizophr Res"},{"key":"5867_CR73","doi-asserted-by":"crossref","unstructured":"Shirayama Y, Obata T, Matsuzawa D, Nonaka H, Kanazawa Y, Yoshitome E, ... & Iyo M (2010) Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: a preliminary study. Neuroimage 49(3):2783-2790","DOI":"10.1016\/j.neuroimage.2009.10.031"},{"issue":"4","key":"5867_CR74","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.neuroimage.2005.10.048","volume":"30","author":"R Srinivasn","year":"2006","unstructured":"Srinivasn R, Cunningham C, Chen A, Vigneron D, Hurd R, Nelson S, Pelletier D (2006) TE-averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T. Neuroimage 30(4):1171\u20131178","journal-title":"Neuroimage"},{"key":"5867_CR75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuroimage.2013.01.009","volume":"86","author":"C Stagg","year":"2014","unstructured":"Stagg C (2014) Magnetic resonance spectroscopy as a tool to study the role of GABA in motor-cortical plasticity. Neuroimage 86:19\u201327","journal-title":"Neuroimage"},{"issue":"5","key":"5867_CR76","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/hipo.1066","volume":"11","author":"DJ Stone","year":"2001","unstructured":"Stone DJ, Walsh JP, Sebro R, Stevens R, Pantazopolous H, Benes FM (2001) Effects of pre-and postnatal corticosterone exposure on the rat hippocampal GABA system. Hippocampus 11(5):492\u2013507","journal-title":"Hippocampus"},{"issue":"6","key":"5867_CR77","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.biopsych.2009.05.006","volume":"66","author":"J Stone","year":"2009","unstructured":"Stone J, Day F, Tsagaraki H, Valli I, McLean M, Lythgoe D, McGuire P (2009) Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biol Psychiat 66(6):533\u2013539","journal-title":"Biol Psychiat"},{"issue":"1","key":"5867_CR78","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.schres.2009.11.011","volume":"117","author":"S Tayoshi","year":"2010","unstructured":"Tayoshi S, Nakataki M, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numala S, Ohmori T (2010) GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study. Schizophr Res 117(1):83\u201391","journal-title":"Schizophr Res"},{"issue":"2","key":"5867_CR79","first-page":"240","volume":"43","author":"R Upthegrove","year":"2017","unstructured":"Upthegrove R, Marwaha S, Birchwood M (2017) Depression and schizophrenia: cause, consequence, or trans-diagnostic issue? Schizophr Bull 43(2):240\u2013244","journal-title":"Schizophr Bull"},{"issue":"2","key":"5867_CR80","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/wps.20310","volume":"15","author":"J Van Os","year":"2016","unstructured":"Van Os J, Reininghaus U (2016) Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry 15(2):118\u2013124","journal-title":"World Psychiatry"},{"issue":"2","key":"5867_CR81","doi-asserted-by":"publisher","first-page":"e30078","DOI":"10.1371\/journal.pone.0030078","volume":"7","author":"C V\u00f6lter","year":"2012","unstructured":"V\u00f6lter C, Strobach T, Aichert DS, W\u00f6stmann N, Costa A, M\u00f6ller HJ, Schubert T, Ettinger U (2012) Schizotypy and behavioural adjustment and the role of neuroticism. PloS One 7(2):e30078","journal-title":"PloS one"},{"issue":"2","key":"5867_CR82","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1037\/a0018399","volume":"119","author":"EF Walker","year":"2010","unstructured":"Walker EF, Brennan PA, Esterberg M, Brasfield J, Pearce B, Compton MT (2010) Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth. J Abnorm Psychol 119(2):401","journal-title":"J Abnorm Psychol"},{"issue":"39","key":"5867_CR83","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1523\/JNEUROSCI.1039-10.2010","volume":"30","author":"T Zhang","year":"2010","unstructured":"Zhang T, Hellstrom I, Bagot R, Wen X, Diorio J, Meaney M (2010) Maternal care and DNA methylation of a glutamic acid decarboxylase 1 promoter in rat hippocampus. J Neuroscience 30(39):131\u2013213","journal-title":"J Neuroscience"},{"issue":"1","key":"5867_CR84","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1109\/42.906424","volume":"20","author":"Y Zhang","year":"2001","unstructured":"Zhang Y, Brady M, Smith S (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20(1):45\u201357","journal-title":"IEEE Trans Med Imaging"},{"issue":"suppl_2","key":"5867_CR85","doi-asserted-by":"publisher","first-page":"S444","DOI":"10.1093\/schbul\/sbu178","volume":"41","author":"Y Wang","year":"2015","unstructured":"Wang Y, Yan C, Yin DZ, Fan MX, Cheung EF, Pantelis C, Chan RC (2015) Neurobiological changes of schizotypy: evidence from both volume-based morphometric analysis and resting-state functional connectivity. Schizophr Bull 41(suppl_2):S444\u2013S454","journal-title":"Schizophr Bull"},{"issue":"6","key":"5867_CR86","first-page":"819","volume":"115","author":"Z Zhang","year":"2002","unstructured":"Zhang Z, Sun J, Reynolds GP (2002) A selective reduction in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia patients. Chin Med J 115(6):819\u2013823","journal-title":"Chin Med J"},{"issue":"6","key":"5867_CR87","first-page":"341","volume":"27","author":"Y Zhilei","year":"2015","unstructured":"Zhilei Y, Yajing Z, Zhenhua S, Li M, Jianye T, Yingchan W, Dengtang L (2015) Comparison of the density of gamma-aminobutyric acid in the ventromedial prefrontal cortex of patients with first-episode psychosis and healthy controls. Shanghai Arch Psychiatry 27(6):341","journal-title":"Shanghai Arch Psychiatry"},{"issue":"11","key":"5867_CR88","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1038\/npp.2013.110","volume":"38","author":"EC Zimmerman","year":"2013","unstructured":"Zimmerman EC, Bellaire M, Ewing SG, Grace AA (2013) Abnormal stress responsivity in a rodent developmental disruption model of schizophrenia. Neuropsychopharmacology 38(11):2131\u20132139","journal-title":"Neuropsychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-05867-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05867-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T16:03:40Z","timestamp":1629302620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-05867-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,19]]},"references-count":88,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5867"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-05867-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,19]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}